25.03.2014 NEXUS AG  DE0005220909

DGAP-Adhoc: NEXUS AG: Substantial sales and revenue growth in 2013


 
NEXUS AG / Key word(s): Final Results 25.03.2014 08:32 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Villingen-Schwenningen, 25 March 2014: NEXUS AG, Villingen-Schwenningen, listed in Prime Standard increased its consolidated sales of KEUR 62,340 in the previous year to KEUR 73,263 (+17.5%) in 2013. The Group annual surplus increased by 26.1% to KEUR 7,220 (previous year: KEUR 5,728). NEXUS AG was again able to achieve two-figure growth both in sales and revenue in 2013 and consequently continue its development of the previous years. Sales in the core business, Health Care Software, increased by 14.1% to KEUR 64,940 (previous year: KEUR 56,921) over the whole year. The Healthcare Service Division had approx. 53.6% higher sales with KEUR 8,323 than in the previous year (KEUR 5,419). The foreign share of Group sales was 42.8% compared to 44.7% in the same period of the previous year. The Group annual surplus was KEUR 7,220 following KEUR 5,728 in 2012 (+26.1%). The Group result before tax on income improved from KEUR 5,789 in 2012 to KEUR 7,078 (+22.3%). The EBITDA reached KEUR 13,998 following KEUR 11,820 in the previous year (+18.4%). The result per share increased by 19.1% to 50 cents (2012: 42 cents). On 31 December 2013, the balance sheet showed stockholders equity amounting to approx. KEUR 72,369 (previous year: KEUR 68,113) as well as cash and securities in the amount of KEUR 23,804 (previous year: KEUR 23,051). There are no essential bank liabilities. The equity capital rate was 71.0%. The Supervisory Board and the Executive Board will proposed at the annual general meeting to pay a dividend of 12 cents per share. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: NEXUS AG - the e-health specialist - develops and sells IT solutions for healthcare systems. These solutions make it possible for hospitals, senior citizen homes, rehabilitation and social institutions to convert to digital patient information. NEXUS also supports integrated healthcare, which enables data exchange between primary care physicians, hospitals and rehabilitation clinics. More than 644 staff members in the NEXUS Group develop Software solutions for the healthcare sector, with which approximately 180,320 users in 25 countries work worldwide on a daily basis. 25.03.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: NEXUS AG Auf der Steig 6 78052 Villingen-Schwenningen Germany Phone: +49 (0)7721 8482-0 Fax: +49 (0)7721 8482-311 E-mail: [email protected] Internet: www.nexus-ag.de ISIN: DE0005220909 WKN: 522090 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 107,05 119,08 136,47 147,65 162,94 188,18 195,00
EBITDA1,2 21,02 23,72 26,71 33,95 36,64 40,77 44,00
EBITDA-Marge3 19,64 19,92 19,57 22,99 22,49 21,67 22,56
EBIT1,4 10,93 13,32 15,18 17,44 19,92 24,11 25,50
EBIT-Marge5 10,21 11,19 11,12 11,81 12,23 12,81 13,08
Jahresüberschuss1 8,61 10,16 11,00 12,12 15,09 17,46 19,00
Netto-Marge6 8,04 8,53 8,06 8,21 9,26 9,28 9,74
Cashflow1,7 16,54 21,68 20,24 24,62 30,95 31,37 33,00
Ergebnis je Aktie8 0,52 0,62 0,69 0,69 0,96 1,09 1,20
Dividende8 0,15 0,16 0,17 0,18 0,19 0,20 0,22
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2021 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Ebner Stolz

INVESTOR-INFORMATIONEN
©boersengefluester.de
Nexus
WKN Kurs in € Einschätzung Börsenwert in Mio. €
522090 50,000 Kaufen 790,73
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
35,46 33,99 1,05 68,68
KBV KCV KUV EV/EBITDA
5,83 25,21 4,20 18,75
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,19 0,20 0,40 29.04.2022
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
17.05.2022 16.08.2022 08.11.2022 08.03.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-1,34% -18,45% -30,17% -20,38%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu NEXUS AG  ISIN: DE0005220909 können Sie bei DGAP abrufen


Software , 522090 , NXU , XETR:NXU